Paragon Therapeutics Appoints Susanna High as Chief Executive Officer | PR Newswire [Video]

In newly created role, High leads a world-class team working to shape the next generation of novel, best-in-class biologics for major medical needs

Former Dyne Therapeutics executive brings deep strategic and operational experience in building and leading fast-growing innovative biotech companies

, /PRNewswire/ — Paragon Therapeutics (“Paragon”), a biotechnology company dedicated to developing best-in-class biologics, announced today that biotech industry veteran Susanna High, MBA, has been appointed as Chief Executive Officer. In this newly created role, High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact.

“I have been impressed and inspired by the Paragon’s mission, scientific excellence, and sense of urgency to advance important novel treatments to patients and I am excited to be working with such a dedicated and accomplished team to maximize the potential of Paragon’s technology and rapidly progress our pipeline,” said High.

“Susanna brings …